Myocardial Perfusion PET
The new frontier in Nuclear Cardiology
Coronary Artery Disease (CAD) affects over 15.5 million Americans and kills over 370,000 annually.1,2 Treating and monitoring such a large, diverse patient population requires diverse approaches.
A common procedure for monitoring the viability of cardiac tissue is Myocardial Perfusion Imaging (MPI). This is often performed using a SPECT camera. However, an exciting recent focus in nuclear cardiology has been the potential of cardiac PET imaging. ASNC and SNMMI released at 2017 joint statement recommending the use of PET for MPI in certain cases. At the 22nd Annual Scientific Session of the American Society of Nuclear Cardiology, in September, 2017, cardiac PET was a major topic of discussion.
However, as with any evolving medical solutions and standards, it is crucial to keep in mind what is the best option for patients. To encourage a greater understanding of this growing application of PET imaging, ASNC has published guidelines reviewing the potential advantages of and recommended clinical conditions for utilizing cardiac PET for MPI. You can download these guidelines by clicking the link below.
Download the ASNC/SNMMI PET Joint Statement and Quick Guide 0.2 MB
ASNC 2017 On-demand Cardiac PET Sessions
ASNC and Siemens Healthineers will also be releasing a series of educational sessions on cardiac PET available to view online. More information on these recorded presentations is listed below. Fill out the form below to view the first educational session and receive email updates as new sessions are released.
Complete the form to view the on-demand ASNC sessions.
Please try again later.
1CDC. (2017, November 28) Heart Disease Facts. https://www.cdc.gov/heartdisease/facts.htm
2Sanchis-Gomar, F., Perez-Quilis, C., Leischik, R., & Lucia, A. (2016). Epidemiology of coronary heart disease and acute coronary syndrome. Annals of Translational Medicine, 4(13), 256. http://doi.org/10.21037/atm.2016.06.33